Update on Moderna’s RSV Vaccine, mRESVIA (mRNA-1345), in Adults ≥60 Years of Age

Das, Rituparna

i

Update on Moderna’s RSV Vaccine, mRESVIA (mRNA-1345), in Adults ≥60 Years of Age

Public Domain

June 26, 2024
By Das, Rituparna
Series: ACIP meeting Respiratory Syncytial Virus Vaccines – Adult

File Language:

English

Details

Personal Author:

Das, Rituparna
Corporate Authors:

Moderna (firm)
Description:

04-RSV-Adult-Das-508.pdf
Subjects:

Respiratory Syncytial Virus, Human Respiratory Syncytial Virus Infections/prevention & Control Respiratory Syncytial Virus Vaccines/adverse Effects Vaccines
Series:

ACIP meeting Respiratory Syncytial Virus Vaccines – Adult
Document Type:

Presentation
Name as Subject:

ACIP meeting: 2024 June 26-28
Genre:

Conference Publications
Place as Subject:

United States
Pages in Document:

24 numbered slides
Collection(s):

Advisory Committee on Immunization Practices (ACIP)
Main Document Checksum:

urn:sha256:651436acbfa98825f6620f4aede80518789b06b40b9e6c25bd74844dabcc38bc
Download URL:

https://stacks.cdc.gov/view/cdc/157864/cdc_157864_DS1.pdf
File Type:

[PDF - 410.84 KB ]

File Language:

English

ON THIS PAGE

Details Related Documents

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.